000	00000cam 2200000zi 4500
001	9.949859
003	CaOODSP
005	20251229124630
006	m     o  d f
007	cr mn|||||||||
008	250407e202508##onc     o    f000 0 eng d
020	|a9780660768533
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aH164-391/2025E-PDF
245	00|aGuidance on biocide : |bannual confirmation and fees for the right to sell biocides.
250	|a[August 2025 edition].
264	1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |cAugust 2025.
264	4|c©2025
300	|a1 online resource (13 pages)
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aCover title.
500	|aIssued also in French under title: Lignes directrices sur la confirmation annuelle des biocides et sur les frais pour le droit de vendre des biocides.
500	|a"Date adopted: 2025/05/31; Date posted: 2025/08/15; Effective date: 2025/05/31"--Page 2.
520	|a"Once a biocide is authorized for sale in Canada, industry must pay an annual fee to retain the right to sell the biocide in Canada. Health Canada has charged fees since 1995 to recover some of the associated costs with post-market regulatory activities such as assessing safety signals and trends and communicating about risks. This document provides guidance on how fees for the right to sell biocides will be administered in accordance with the Food and Drugs Act and as stipulated in the Fees in Respect of Drugs and Medical Devices Order"--Page 5.
650	0|aDisinfectants industry|xGovernment policy|zCanada.
650	0|aFees, Administrative|zCanada.
710	1 |aCanada. |bHealth Canada, |eissuing body.
775	08|tLignes directrices sur la confirmation annuelle des biocides et sur les frais pour le droit de vendre des biocides.|w(CaOODSP)9.949860
794	|tGuidance on biocide : |b[November 2025 edition]|w(CaOODSP)9.957053
856	40|qPDF|s415 KB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H164-391-2025-eng.pdf
986	|a250008